Regencell Bioscience Holdings Limited (RGC) — QMA analysis
Sector: Healthcare · Market cap: $13.8B · Price: $7.67 · Data as of 2026-10-23
Regencell Bioscience Holdings Limited has a below-average composite score of 38/100, higher score than 25% of 22,734 tracked stocks. The highest-scoring layer is Momentum; the lowest is Insider activity.
What 6 data layers say about RGC
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 40/100 |
| Technical trend (TSS) | 36/100 |
| Relative strength (RS) | 33/100 |
| Momentum (USS) | 58/100 |
| Insider activity (IAS) | 27/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 40/100 |
What does the QMA model currently show for Regencell Bioscience Holdings Limited?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For RGC the layers diverge — some score high (Momentum), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
RGC insider & smart money activity
For RGC we track the institutional footprint through FINRA off-exchange trading data (WHS 40/100). Detailed insider data for this stock is still being collected.
RGC seasonality
RGC is currently in its seasonal window October 1–28 with a hit rate of 67% and an average move of 4.7% (6 years of history).
Historical data does not guarantee future results.
RGC dividend
Regencell Bioscience Holdings Limited: 100.00%
How RGC compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for RGC stock?
38/100 (D) — Data as of 2026-10-23.
Are insiders buying RGC stock?
—
Where can I see live RGC data?
Live RGC data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]